Archive for November, 2019
Trading volume is going to be thin today, due to the holiday, so I wanted to take this chance to say that I I am thankful for the support of my team and more importantly you the reader. I hope you all had a happy Thanksgiving.
I’ll still be keeping one eye on the market today, watching for key developments. I’ll be back next week to report on what I’ve noticed, and give my recommendations as the market heads into the final month of this year…
There’s a memo going around Wall Street.
It says to stay away from investing in Chinese stocks during our trade battles with that nation.
It’s a good thing that someone forgot to give Daniel Zhang a copy.
Here’s the thing. While tariffs the U.S. imposed on some Chinese goods have slowed factory output over there, that has hardly filtered down to the nation’s thriving Web sector.
And that’s where Zhang is really shining right now. He’s the CEO of Internet giant Alibaba Group Holding Ltd. (BABA) and just pulled off a remarkable coup.
In the first hour of the firm’s recent Single’s Day shopping bonanza Nov. 11, it brought in $13 billion. No, that’s not a misprint. Alibaba sold more goods in 60 minutes than hundreds of U.S. firms do in a year.
By contrast, that’s roughly 80% of what Amazon.com Inc. (AMZN) pulled in last quarter.
With that in mind, today I going to reveal five reasons why this stock will continue to beat the broad U.S. market by more than 30% a year…
Imagine if all it took to treat a case of cancer was taking out the trash.
Now I want you to imagine that your body could do it all for you.
Hold that thought. Because a tech platform with that very task in mind is set to hit the market sooner than you think and will target a field set to be worth more than $160 billion.
Here’s the thing. Several life sciences firms are hard at work perfecting a new class of drugs known as “degraders.”
Let me explain. The root of many diseases lies in misguided proteins that bind together. So, the idea here is to come up with a new class of drugs that activate the body’s own molecular trash disposal systems.
This is one of the most exciting breakthroughs I’ve come across in many years. I believe it puts us close to the day when one pill can cure dozens, if not all, diseases.
And in a moment, I’m going to reveal a way investors can target the entire class of protein degraders with one savvy move…
I sure hope you took the advice I gave you back on July 26. You’d be laughing all the way to the bank by now.
But even if you didn’t have a chance to read it, today I’m going to show you why there’s so much upside for this company ahead.
Back then, my column about a breakout medtech leader appeared the very day after the stock dropped by 25% on heavy volume.
That’s the kind of decline that makes most investors very nervous.
But we’re not most investors. We know how to pounce on an undervalued stock and make more money by turning Wall Street’s anxiety attack into our long-term profits.
And that’s why I never lost faith in this company. It’s one I have followed for years and it’s nothing short of a profit powerhouse.
In fact, I actually got excited to see that we could scoop up shares of Align Technology Inc. (ALGN) at deep discount.
So, I’m happy to report that Align rocked the market last month – gaining more than 39% in just 30 days.
But that might be just the beginning…
By now, I think it’s safe to say that Jim Cramer was dead wrong.
And I was right on the money.
Here’s the thing. I remember very clearly the day that Amazon.com Inc. (AMZN) crossed the $1,000 mark on May 31, 2017.
Cramer, the host of CNBC’s Mad Money looked at the price and slammed it. He said that “psychologically” $1,000 is a lot to pay for a stock he felt was getting ahead of itself.
As the saying goes, that was then and this is now.
No doubt, the tech leader hit a rough patch late last year with the rest of the market. And it has come under fire recently as part of the Big Tech backlash.
Yet, below-expected earnings reports for Q2 and Q3 of this year could only pull Amazon down into the $1,700 range, still far above what Cramer was worrying about.
Not only that, but the “King of E-commerce” is well positioned for another historic moment. It’s roughly 15% away from having a $1 trillion market cap, and most of that would just be regaining lost ground
And today, you’ll see why I still firmly believe the stock will hit at least $3,000 a share – and likely much, much more than that…
Check it out…
In Plato’s Republic, protagonist Socrates takes the Delphic aphorism “Know Thyself” as his personal motto.
It’s a great motto … especially for investors.
As a market veteran of many years, I can tell you that this is one of the biggest weaknesses most investors have.
They don’t know themselves …
I watch as folks take losses and miss out on profits – mistakes they could have easily avoided if they’d only taken the time to know their investing personalities just a little bit better.
So today I want to demonstrate how to transform yourself into the “Socrates of High-Tech Investing.”
It’s easier than you’d think…
My wife and I recently traveled nearly 20 hours to return from a trip to Barcelona only to get out of bed the next morning and have no electricity.
Here’s the thing, when you don’t have power, you don’t have comms. We had no Wifi since the provider didn’t have enough back up power in place.
Even more frustrating was that our smart phones were all but useless. Forget surfing the Web to get information about PG&E Corp. (PCG) and its planned shutoffs.
On top of all that, we had no real cell service, meaning we couldn’t make calls from our home. Our neighbors said that their land lines were also useless.
That’s when it really drove home something that we all take for granted -modern communications like text messages, email and phones are totally integral to our lives.
They’re so important that the goal of unifying all these services recently led to a $500 million deal for a cloud-based communications firm.
Today, I’m going to reveal the winner of this new pact and show you why it will more than triple the market’s returns…
Roku Inc. (ROKU) has been having some good days in early November, and it’s perfectly positioned to capitalize on the rise of streaming; but its future is not necessarily certain. The streaming platform has had to deal with some price instability after its quick rise, and now the question of whether its freemium pricing model can meet consumer demand is surfacing. Meanwhile, the digital streaming market is full of tough competitors – and there are two more prominent than ever, ready to hash it out. This is one battle you need to watch closely, as the winner could spell out huge profits for whomever latches on now. Click here to watch.
BARCELONA, Spain – Most folks visiting this historic port city on the Balearic sea would focus on seeing tourist-facing sites like the huge and elaborate Sagrada Familia church or the Gothic district.
But I made finding a cannabis club a very high priority.
And this was for two reasons:
- Even though I use edibles to help me sleep at night, my wife and I dared not go through customs with contraband of any kind.
- Having talked to many of you members about global cannabis sales in the years ahead, I wanted to see firsthand how the sector is doing in Europe.
I’m happy to report that cannabis use and sales are on the upswing in this port city and that Europe is set to help drive a global market forecast to hit $15 billion this year.
Today, I’m going to reveal to you what my visit to just such a club reveals about the opportunities available in this high-octane sector…
I recently got the kind of news that no child wants to hear about an aging parent.
Here’s the thing, I count my blessings that my dad lived so long. After all, he’s a retired Marine Corps captain who saw three tours of combat, one in Korea and two in Vietnam.
Honestly he’s lucky he lived as long as he did. But that still doesn’t make the aging process any easier, at least not on the body.
He recently had a second knee replacement that didn’t go as well as planned. He also has swelling of the feet. His mobility is not all that great, and he can’t drive right now.
At 86, he recently learned he has congestive heart failure. That’s a condition in which the heart doesn’t pump as strongly as it should, leading to a buildup of fluids.
As such, my dad is part of a huge trend in America. Fact is, according to the American Heart Association, cardiovascular disease is set to have an economic impact of $1.1 trillion by 2035.
And today, I want to reveal a life sciences firm that is bringing badly needed relief to millions of heart patients, and show you five reasons why it’s set to double in as little as 3.5 years…